rosiglitazone has been researched along with Anoxia-Ischemia, Brain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egea, J; García, AG; López, MG; Martínez, A; Rosa, AO | 1 |
1 other study(ies) available for rosiglitazone and Anoxia-Ischemia, Brain
Article | Year |
---|---|
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors.
Topics: Anilides; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; L-Lactate Dehydrogenase; Male; MAP Kinase Signaling System; Neuroprotective Agents; Organ Culture Techniques; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiadiazoles; Thiazolidinediones | 2008 |